Serum Biomarkers in Diagnosis of Mesothelioma

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2010

Study Completion Date

October 31, 2013

Conditions
Mesothelioma
Interventions
BIOLOGICAL

Mesothelin, hyaluronan, osteopontin, syndecan-1

We compere the serum levels of the tumor markers in patients with pleural diseases according to the groups for the diagnosis and differential diagnosis of the diseases.

Trial Locations (1)

260240

ESOGU Lung and Pleural Cancer Application and Research Center, Eskişehir

All Listed Sponsors
lead

Eskisehir Osmangazi University

OTHER

NCT02029105 - Serum Biomarkers in Diagnosis of Mesothelioma | Biotech Hunter | Biotech Hunter